Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 20 Source: CRO
- €2.3 billion turnover
-
€1.3 billion
profit - 400 employees
-
31st Dec 19 Source: CRO
- €2.5 billion turnover
-
€1.5 billion
profit - 400 employees
- 6 more years available »
Ranking
By Turnover
(€2.3 billion)- 53rd in Top Companies
- 10th in Health
- 9th in Pharma
By Employees
(400)- 419th in Top Companies
- 62nd in Health
- 35th in Pharma
- 400
- €2.3 billion
Employees
- Shane Doyle Senior vice president
Latest News
- 5:55am Consumer giant Procter & Gamble sells last Irish manufacturing plant
- 2:02am Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash